|
YMAB Y-mabs Therapeutics Inc 1722964 |
| Balance Sheet |
|
Current Assets
|
98,509,000 |
|
Assets
|
119,904,000 |
|
Current Liabilities
|
23,698,000 |
|
Liabilities
|
27,900,000 |
|
Equity
|
92,004,000 |
|
Shares Out
|
44,570,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-15,714,000 |
| Market Analysis |
Market Cap
|
626,206,120 |
|
Price
|
4.91 |
|
BVPS
|
2.06 |
|
PB
|
2.35 |
|
EPS
|
-0.56 |
|
PS
|
1.79 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/29 |
-0.02 |
3/4 |
-0.67 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view YMAB documents filed with the SEC.
YMAB Filings
Clear
